共 38 条
- [24] Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (09) : 978 - 997
- [27] Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed JOURNAL OF AFFECTIVE DISORDERS, 2016, 196 : 225 - 233
- [28] Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (04) : 356 - 368
- [29] Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (11) : 1089 - 1104
- [30] Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (01) : 60 - 82